Tenofovir Plasma Concentration From Pre-Exposure Prophylaxis (PrEP) at the Time of Potential HIV Exposure: A Population Pharmacokinetic Modeling and Simulation Study Involving Serodiscordant Couples in East Africa

Antimicrobial Agents and Chemotherapy - United States

doi 10.1128/aac.00446-19